Literature DB >> 1590470

Acute effects of captopril, an angiotensin-converting enzyme inhibitor, on the pregnant ewe and fetus.

E R Lumbers1, N M Kingsford, R I Menzies, A D Stevens.   

Abstract

After control measurements had been made, 15 chronically catheterized pregnant ewes (gestational age 123-141 days) were given 15 mg of captopril intravenously followed by an infusion of 6 mg/h. These doses blocked the pressor responses of both ewes and fetuses to 5 micrograms of angiotensin I. After captopril, maternal mean arterial pressure fell from 94 +/- 3.5 to 88 +/- 3.6 (SE) mmHg (P less than 0.0001) and pulse interval fell (P = 0.008). Maternal flow to the cotyledons fell from 766 +/- 118 to 525 +/- 77 ml/min (P = 0.002), as did flow to the remainder of the maternal placenta, i.e., the caruncles and their underlying myoendometrium (control flow 188 +/- 35 ml/min, flow 10-15 min after captopril 166 +/- 36.1 ml/min; P = 0.021). Flow to the rest of the myometrium did not change. Fetal arterial pressure fell from 46.9 +/- 1.6 to 44.1 +/- 1.6 mmHg (P less than 0.009), and fetal placental blood flow fell from 639.9 +/- 93.2 to 413.1 +/- 53.9 ml/min (P = 0.025). Flow to the fetal membranes declined also, from 53.2 +/- 6.5 to 35.6 +/- 3.3 ml/min (P less than 0.005). Maternal and fetal renal blood flows and fetal adrenal blood flows were unchanged. Fetal arterial PO2 was initially 19.5 +/- 0.8 mmHg; after captopril, it was 17.7 +/- 0.9 mmHg (P = 0.03).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590470     DOI: 10.1152/ajpregu.1992.262.5.R754

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Restriction of placental and fetal growth in sheep alters fetal blood pressure responses to angiotensin II and captopril.

Authors:  L J Edwards; G Simonetta; J A Owens; J S Robinson; I C McMillen
Journal:  J Physiol       Date:  1999-03-15       Impact factor: 5.182

2.  Chronic captopril treatment reveals the role of ANG II in cardiovascular function of embryonic American alligators (Alligator mississippiensis).

Authors:  Casey A Mueller; John Eme; Kevin B Tate; Dane A Crossley
Journal:  J Comp Physiol B       Date:  2018-04-06       Impact factor: 2.200

3.  Comparison of angiotensin II type 1 receptor blockade and angiotensin-converting enzyme inhibition in pregnant sheep during late gestation.

Authors:  A J Forhead; K Whybrew; P Hughes; F Broughton Pipkin; M Sutherland; A L Fowden
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

4.  Effects of angiotensin II in fetal sheep and modification of its actions by indomethacin.

Authors:  K M Stevenson; E R Lumbers
Journal:  J Physiol       Date:  1995-08-15       Impact factor: 5.182

Review 5.  An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.

Authors:  H S Buttar
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

6.  Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.

Authors:  K M Stevenson; K J Gibson; E R Lumbers
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

7.  Effects of captopril on the human foetal placental circulation: an interaction with bradykinin and angiotensin I.

Authors:  R de Moura; M A Lopes
Journal:  Br J Clin Pharmacol       Date:  1995-05       Impact factor: 4.335

8.  The effects of a converting enzyme inhibitor (captopril) and angiotensin II on fetal renal function.

Authors:  E R Lumbers; J H Burrell; R I Menzies; A D Stevens
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.